Blueprint Medicines Corp Stock
Your prediction
Blueprint Medicines Corp Stock
So far the community has only identified positive things for Blueprint Medicines Corp stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Blueprint Medicines Corp in the next few years
Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Blueprint Medicines Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | - | - | - | - | - | - | - |
| Ligand Pharmaceuticals | -3.820% | -0.781% | -9.286% | 117.094% | 53.012% | 319.835% | 171.194% |
| United Therapeutics | -0.580% | 3.809% | -5.572% | 81.464% | 9.057% | 115.541% | 156.044% |
| Ionis Pharmaceuticals Inc. | 1.990% | 8.773% | -35.384% | 39.931% | -28.119% | 37.451% | 47.985% |
News
ExxonMobil Q2 Earnings Call Highlights
ExxonMobil (NYSE:XOM) reported second-quarter earnings of $14.5 billion and cash flow from operations of $23.6 billion, as the company said
Applied Digital Is Building a $36 Billion AI Real Estate Empire
Key Points
- Interested in Applied Digital Corporation? Here are five stocks we like better.
- Applied Digital finalized a 15-year, 210-megawatt lease at Delta Forge 2, locking in approximately $36
Webull Q1 Earnings Call Highlights
Key Points
- Interested in Webull Corporation? Here are five stocks we like better.
- Webull posted strong Q1 growth, with revenue up 36% year over year to $159.9 million as trading activity